The European Union should allow drug prices to rise to U.S. levels in order to attract investment, the bosses of two European ...

Top Swiss officials will this week test whether big commitments to the U.S. can help secure relief from import tariffs, after pharma giant Roche followed its cross-town rival Novartis in announcing ...

Background This paper examines top-selling electronic cigarette (e-cigarette) brands and differences in top-selling brands by region in the USA from 2022 to 2024, and the market share of Food and Drug ...

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

Adding to the list of pharma majors starting or expanding production in the USA, Swiss pharma giant Roche (ROG: SIX) today announced that it will invest $50 billion into America in the next five years ...

The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

The pharmaceutical company will build six new production sites and one for research and development in the USA. This will ...

Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump administration buffets global trade with tariffs.

Swiss pharma giant Novartis (NOVN: VX) has announced a planned $23 billion investment over five years in US-based ...

Global drugmaker Novartis will lay off 427 employees in East Hanover this spring and summer, after it let go of 235 at the Morris County site last year, filings with the New Jersey Department of ...

Global drugmaker Novartis will lay off 427 employees who report to the company's East Hanover headquarters this spring and summer, after it let go of 235 at the Morris County site last year ...